Home

  • Order to parcel locker

    Order to parcel locker

  • easy pay

    easy pay
  • Reduced price
CAR T-Cell, An Issue of Hematology/Oncology Clinics of North America

CAR T-Cell, An Issue of Hematology/Oncology Clinics of North America

9780443183003
PRINT ON DEMAND - DELIVERY CAN TAKE UP TO 14 DAYS
483.79 zł
411.22 zł Save 72.57 zł Tax included
Lowest price within 30 days before promotion: 411.22 zł
Quantity
Available in 4-6 weeks

  Delivery policy

Choose Paczkomat Inpost, Orlen Paczka, DPD or Poczta Polska. Click for more details

  Security policy

Pay with a quick bank transfer, payment card or cash on delivery. Click for more details

  Return policy

If you are a consumer, you can return the goods within 14 days. Click for more details

Description
In this issue of Hematology/Oncology Clinics, guest editors Drs. Caron A. Jacobson and Parth S. Shah bring their considerable expertise to the topic of CAR T-Cell Therapy. Top experts in the field discuss the multiple ways CAR T-cell therapy can be used to help fight a variety of cancers, such as diffuse large B-cell lymphoma (DLBCL), follicular lymphoma, mantle cell lymphoma, multiple myeloma, and B-cell acute lymphoblastic leukemia (ALL).
Product Details
Elsevier
99497
9780443183003
9780443183003

Data sheet

Publication date
2023
Issue number
1
Cover
hard cover
Pages count
240
Dimensions (mm)
152 x 229
Weight (g)
450
  • The Current State of Chimeric Antigen Receptor T Cell Therapy for B Lymphoblastic Leukemia
    Chimeric Antigen Receptor T-Cell Therapy in Aggressive B-Cell Lymphoma
    Chimeric Antigen Receptor T-Cells in Indolent Lymphoma, Mantle Cell Lymphoma, Chronic Lymphocytic Leukemia
    Chimeric Antigen Receptor T Cells in Multiple Myeloma
    Chimeric Antigen Receptor T Cells in Hodgkin and T-Cell Lymphomas
    Chimeric Antigen Receptor T Cells in Acute Myeloid Leukemia
    Chimeric Antigen Receptor T-Cell Therapy for Solid Tumors
    Early and Late Toxicities of Chimeric Antigen Receptor T-Cells
    Mechanisms of Resistance to Chimeric Antigen Receptor T Cell Therapy
    The Role of Chimeric Antigen Receptor T-Cell Therapy in the Era of Bispecific Antibodies
    The Future of Chimeric Antigen Receptor T Cell Therapy
Comments (0)